StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)

Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –

Ironwood Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Ironwood Pharmaceuticals's total assets was $285.13M at Jun 30, 2026. For fiscal 2025 it was $396.90M, up 13.1% from the year before. Over ten years it grew -4.3% a year on average. The highest annual figure on record is $1.13B in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$396.90M+13.1%
FY2024Dec 31, 2024$350.91M-25.5%
FY2023Dec 31, 2023$471.07M-57.2%
FY2022Dec 31, 2022$1.10B-2.3%
FY2021Dec 31, 2021$1.13B+101.5%
FY2020Dec 31, 2020$559.24M+38.9%
FY2019Dec 31, 2019$402.75M+21.3%
FY2018Dec 31, 2018$332.05M-45.2%
FY2017Dec 31, 2017$605.67M-14.7%
FY2016Dec 31, 2016$709.82M+14.6%
FY2015Dec 31, 2015$619.12M+88.0%
FY2014Dec 31, 2014$329.32M+18.1%
FY2013Dec 31, 2013$278.96M+21.3%
FY2012Dec 31, 2012$229.91M+10.0%
FY2011Dec 31, 2011$208.98M-30.7%
FY2010Dec 31, 2010$301.37M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$285.13M-16.9%
Q1 FY2026Mar 31, 2026$434.57M+32.8%
Q4 FY2025Dec 31, 2025$396.90M+13.1%
Q3 FY2025Sep 30, 2025$396.06M+1.7%
Q2 FY2025Jun 30, 2025$342.95M-13.3%
Q1 FY2025Mar 31, 2025$327.21M-25.4%
Q4 FY2024Dec 31, 2024$350.91M-25.5%
Q3 FY2024Sep 30, 2024$389.52M-25.7%
Q2 FY2024Jun 30, 2024$395.62M-34.4%
Q1 FY2024Mar 31, 2024$438.82M-62.0%
Q4 FY2023Dec 31, 2023$471.07M-57.2%
Q3 FY2023Sep 30, 2023$524.06M-49.6%
Q2 FY2023Jun 30, 2023$603.22M-38.2%
Q1 FY2023Mar 31, 2023$1.16B+6.6%
Q4 FY2022Dec 31, 2022$1.10B-2.3%
Q3 FY2022Sep 30, 2022$1.04B-3.6%
Q2 FY2022Jun 30, 2022$975.69M-3.1%
Q1 FY2022Mar 31, 2022$1.08B+80.8%
Q4 FY2021Dec 31, 2021$1.13B+101.5%
Q3 FY2021Sep 30, 2021$1.08B+119.2%
Q2 FY2021Jun 30, 2021$1.01B+127.1%
Q1 FY2021Mar 31, 2021$599.34M+48.4%
Q4 FY2020Dec 31, 2020$559.24M+38.9%
Q3 FY2020Sep 30, 2020$492.32M+47.3%
Q2 FY2020Jun 30, 2020$443.54M+40.5%
Q1 FY2020Mar 31, 2020$404.01M+11.1%
Q4 FY2019Dec 31, 2019$402.75M+21.3%
Q3 FY2019Sep 30, 2019$334.34M-19.8%
Q2 FY2019Jun 30, 2019$315.72M-48.9%
Q1 FY2019Mar 31, 2019$363.54M-36.3%
Q4 FY2018Dec 31, 2018$332.05M-45.2%
Q3 FY2018Sep 30, 2018$416.65M-33.3%
Q2 FY2018Jun 30, 2018$618.22M-12.3%
Q1 FY2018Mar 31, 2018$571.10M-18.6%
Q4 FY2017Dec 31, 2017$605.67M-14.7%
Q3 FY2017Sep 30, 2017$625.09M-14.6%
Q2 FY2017Jun 30, 2017$705.08M–
Q1 FY2017Mar 31, 2017$701.32M–
Q4 FY2016Dec 31, 2016$709.82M–
Q3 FY2016Sep 30, 2016$731.98M–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?